Victrex shares sink after reporting 17% profit decline in H1; outlook updated

Published 12/05/2025, 08:20
© Reuters.

Investing.com -- U.K. polymer supplier Victrex (LON:VCTX) reported a weaker-than-expected performance for the first half of fiscal 2025, with profits falling short despite an increase in volumes.

The company’s shares tumbled more than 7% after the market open in London.  

Victrex posted pretax profit of £23.2 million, down 17% from the previous year and below the £26.4 million estimated by Jefferies analysts. Group revenue came in at £145.9 million, while volumes grew 16% year-on-year to 2,018 tonnes.

Meanwhile, average selling prices (ASPs) declined to £72.3/kg from a previous guide of £75/kg-£80/kg, weighing on margins. Gross margin narrowed by 390 basis points to 44.1%.

It also flagged a £40.7 million net debt position.

The company faced continued headwinds from foreign exchange, weak Medical (TASE:BLWV) demand, and higher costs tied to its China expansion. 

Management upgraded its volume outlook for full-year 2025 to high single-digit growth, up from “at least mid-single-digit,” but warned of lingering risks from global trade tensions and a still-challenging product mix. Second-half profit is now expected to be in line with the £31.1 million posted in second half of 2024.

Jefferies analysts said the update implies around a 15% downgrade to full-year consensus and their own forecasts.

“There continues to be very few signs of a Medical recovery, and when this mix headwind is combined with FX & China ramp-up costs, profitability continues to be challenging,” they wrote, adding they expect a negative share price reaction, and double-digit consensus downgrades.

"We still see Victrex as an attractive cyclical recovery story, and valuation is attractive, but it is clear that we need some signs of life in Medical before we can see any earnings progress," the analysts continued. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.